Cargando…
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356449/ https://www.ncbi.nlm.nih.gov/pubmed/30621045 http://dx.doi.org/10.3390/md17010032 |
_version_ | 1783391544275894272 |
---|---|
author | van Weelden, Geert Bobiński, Marcin Okła, Karolina van Weelden, Willem Jan Romano, Andrea Pijnenborg, Johanna M. A. |
author_facet | van Weelden, Geert Bobiński, Marcin Okła, Karolina van Weelden, Willem Jan Romano, Andrea Pijnenborg, Johanna M. A. |
author_sort | van Weelden, Geert |
collection | PubMed |
description | Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relation to its anti-cancer mechanisms. The general bioactivity of fucoidan is difficult to establish due to factors like species-related structural diversity, growth conditions, and the extraction method. The main pathways influenced by fucoidan are the PI3K/AKT, the MAPK pathway, and the caspase pathway. PTEN seems to be important in the fucoidan-mediated effect on the AKT pathway. Furthermore, the interaction with VEGF, BMP, TGF-β, and estrogen receptors are discussed. Also, fucoidan as an adjunct seems to have beneficial effects, for both the enhanced effectiveness of chemotherapy and reduced toxicity in healthy cells. In conclusion, the multipotent character of fucoidan is promising in future anti-cancer treatment. However, there is a need for more specified studies of the structure–activity relationship of fucoidan from the most promising seaweed species. |
format | Online Article Text |
id | pubmed-6356449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63564492019-02-05 Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms van Weelden, Geert Bobiński, Marcin Okła, Karolina van Weelden, Willem Jan Romano, Andrea Pijnenborg, Johanna M. A. Mar Drugs Review Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relation to its anti-cancer mechanisms. The general bioactivity of fucoidan is difficult to establish due to factors like species-related structural diversity, growth conditions, and the extraction method. The main pathways influenced by fucoidan are the PI3K/AKT, the MAPK pathway, and the caspase pathway. PTEN seems to be important in the fucoidan-mediated effect on the AKT pathway. Furthermore, the interaction with VEGF, BMP, TGF-β, and estrogen receptors are discussed. Also, fucoidan as an adjunct seems to have beneficial effects, for both the enhanced effectiveness of chemotherapy and reduced toxicity in healthy cells. In conclusion, the multipotent character of fucoidan is promising in future anti-cancer treatment. However, there is a need for more specified studies of the structure–activity relationship of fucoidan from the most promising seaweed species. MDPI 2019-01-07 /pmc/articles/PMC6356449/ /pubmed/30621045 http://dx.doi.org/10.3390/md17010032 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review van Weelden, Geert Bobiński, Marcin Okła, Karolina van Weelden, Willem Jan Romano, Andrea Pijnenborg, Johanna M. A. Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
title | Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
title_full | Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
title_fullStr | Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
title_full_unstemmed | Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
title_short | Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
title_sort | fucoidan structure and activity in relation to anti-cancer mechanisms |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356449/ https://www.ncbi.nlm.nih.gov/pubmed/30621045 http://dx.doi.org/10.3390/md17010032 |
work_keys_str_mv | AT vanweeldengeert fucoidanstructureandactivityinrelationtoanticancermechanisms AT bobinskimarcin fucoidanstructureandactivityinrelationtoanticancermechanisms AT okłakarolina fucoidanstructureandactivityinrelationtoanticancermechanisms AT vanweeldenwillemjan fucoidanstructureandactivityinrelationtoanticancermechanisms AT romanoandrea fucoidanstructureandactivityinrelationtoanticancermechanisms AT pijnenborgjohannama fucoidanstructureandactivityinrelationtoanticancermechanisms |